Using the heat-shock response to discover anticancer compounds that target protein homeostasis

Sandro Santagata, Ya Ming Xu, E. M Kithsiri Wijeratne, Renee Kontnik, Christine Rooney, Casey C. Perley, Hyoungtae Kwon, Jon Clardy, Santosh Kesari, Luke Whitesell, Susan Lindquist, Leslie Gunatilaka

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Unlike normal tissues, cancers experience profound alterations in protein homeostasis. Powerful innate adaptive mechanisms, especially the transcriptional response regulated by Heat Shock Factor 1 (HSF1), are activated in cancers to enable survival under these stressful conditions. Natural products that further tax these stress responses can overwhelm the ability to cope and could provide leads for the development of new, broadly effective anticancer drugs. To identify compounds that drive the HSF1-dependent stress response, we evaluated over 80,000 natural and synthetic compounds as well as partially purified natural product extracts using a reporter cell line optimized for high-throughput screening. Surprisingly, many of the strongly active compounds identified were natural products representing five diverse chemical classes (limonoids, curvularins, withanolides, celastraloids, and colletofragarones). All of these compounds share the same chemical motif, an α,β- unsaturated carbonyl functionality, with strong potential for thiol-reactivity. Despite the lack of a priori mechanistic requirements in our primary phenotypic screen, this motif was found to be necessary albeit not sufficient, for both heat-shock activation and inhibition of glioma tumor cell growth. Within the withanolide class, a promising therapeutic index for the compound withaferin A was demonstrated in vivo using a stringent orthotopic human glioma xenograft model in mice. Our findings reveal that diverse organisms elaborate structurally complex thiol-reactive metabolites that act on the stress responses of heterologous organisms including humans. From a chemical biology perspective, they define a robust approach for discovering candidate compounds that target the malignant phenotype by disrupting protein homeostasis.

Original languageEnglish (US)
Pages (from-to)340-349
Number of pages10
JournalACS Chemical Biology
Volume7
Issue number2
DOIs
StatePublished - Feb 17 2012

Fingerprint

Heat-Shock Response
Withanolides
Biological Products
Homeostasis
Sulfhydryl Compounds
Glioma
Shock
Hot Temperature
Limonins
Neoplasms
Proteins
Cell growth
Metabolites
Taxation
Heterografts
Tumors
Screening
Chemical activation
Cells
Throughput

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Santagata, S., Xu, Y. M., Wijeratne, E. M. K., Kontnik, R., Rooney, C., Perley, C. C., ... Gunatilaka, L. (2012). Using the heat-shock response to discover anticancer compounds that target protein homeostasis. ACS Chemical Biology, 7(2), 340-349. https://doi.org/10.1021/cb200353m

Using the heat-shock response to discover anticancer compounds that target protein homeostasis. / Santagata, Sandro; Xu, Ya Ming; Wijeratne, E. M Kithsiri; Kontnik, Renee; Rooney, Christine; Perley, Casey C.; Kwon, Hyoungtae; Clardy, Jon; Kesari, Santosh; Whitesell, Luke; Lindquist, Susan; Gunatilaka, Leslie.

In: ACS Chemical Biology, Vol. 7, No. 2, 17.02.2012, p. 340-349.

Research output: Contribution to journalArticle

Santagata, S, Xu, YM, Wijeratne, EMK, Kontnik, R, Rooney, C, Perley, CC, Kwon, H, Clardy, J, Kesari, S, Whitesell, L, Lindquist, S & Gunatilaka, L 2012, 'Using the heat-shock response to discover anticancer compounds that target protein homeostasis', ACS Chemical Biology, vol. 7, no. 2, pp. 340-349. https://doi.org/10.1021/cb200353m
Santagata S, Xu YM, Wijeratne EMK, Kontnik R, Rooney C, Perley CC et al. Using the heat-shock response to discover anticancer compounds that target protein homeostasis. ACS Chemical Biology. 2012 Feb 17;7(2):340-349. https://doi.org/10.1021/cb200353m
Santagata, Sandro ; Xu, Ya Ming ; Wijeratne, E. M Kithsiri ; Kontnik, Renee ; Rooney, Christine ; Perley, Casey C. ; Kwon, Hyoungtae ; Clardy, Jon ; Kesari, Santosh ; Whitesell, Luke ; Lindquist, Susan ; Gunatilaka, Leslie. / Using the heat-shock response to discover anticancer compounds that target protein homeostasis. In: ACS Chemical Biology. 2012 ; Vol. 7, No. 2. pp. 340-349.
@article{fa0fd04d521b4ace9b524b4fa99b0b30,
title = "Using the heat-shock response to discover anticancer compounds that target protein homeostasis",
abstract = "Unlike normal tissues, cancers experience profound alterations in protein homeostasis. Powerful innate adaptive mechanisms, especially the transcriptional response regulated by Heat Shock Factor 1 (HSF1), are activated in cancers to enable survival under these stressful conditions. Natural products that further tax these stress responses can overwhelm the ability to cope and could provide leads for the development of new, broadly effective anticancer drugs. To identify compounds that drive the HSF1-dependent stress response, we evaluated over 80,000 natural and synthetic compounds as well as partially purified natural product extracts using a reporter cell line optimized for high-throughput screening. Surprisingly, many of the strongly active compounds identified were natural products representing five diverse chemical classes (limonoids, curvularins, withanolides, celastraloids, and colletofragarones). All of these compounds share the same chemical motif, an α,β- unsaturated carbonyl functionality, with strong potential for thiol-reactivity. Despite the lack of a priori mechanistic requirements in our primary phenotypic screen, this motif was found to be necessary albeit not sufficient, for both heat-shock activation and inhibition of glioma tumor cell growth. Within the withanolide class, a promising therapeutic index for the compound withaferin A was demonstrated in vivo using a stringent orthotopic human glioma xenograft model in mice. Our findings reveal that diverse organisms elaborate structurally complex thiol-reactive metabolites that act on the stress responses of heterologous organisms including humans. From a chemical biology perspective, they define a robust approach for discovering candidate compounds that target the malignant phenotype by disrupting protein homeostasis.",
author = "Sandro Santagata and Xu, {Ya Ming} and Wijeratne, {E. M Kithsiri} and Renee Kontnik and Christine Rooney and Perley, {Casey C.} and Hyoungtae Kwon and Jon Clardy and Santosh Kesari and Luke Whitesell and Susan Lindquist and Leslie Gunatilaka",
year = "2012",
month = "2",
day = "17",
doi = "10.1021/cb200353m",
language = "English (US)",
volume = "7",
pages = "340--349",
journal = "ACS Chemical Biology",
issn = "1554-8929",
publisher = "American Chemical Society",
number = "2",

}

TY - JOUR

T1 - Using the heat-shock response to discover anticancer compounds that target protein homeostasis

AU - Santagata, Sandro

AU - Xu, Ya Ming

AU - Wijeratne, E. M Kithsiri

AU - Kontnik, Renee

AU - Rooney, Christine

AU - Perley, Casey C.

AU - Kwon, Hyoungtae

AU - Clardy, Jon

AU - Kesari, Santosh

AU - Whitesell, Luke

AU - Lindquist, Susan

AU - Gunatilaka, Leslie

PY - 2012/2/17

Y1 - 2012/2/17

N2 - Unlike normal tissues, cancers experience profound alterations in protein homeostasis. Powerful innate adaptive mechanisms, especially the transcriptional response regulated by Heat Shock Factor 1 (HSF1), are activated in cancers to enable survival under these stressful conditions. Natural products that further tax these stress responses can overwhelm the ability to cope and could provide leads for the development of new, broadly effective anticancer drugs. To identify compounds that drive the HSF1-dependent stress response, we evaluated over 80,000 natural and synthetic compounds as well as partially purified natural product extracts using a reporter cell line optimized for high-throughput screening. Surprisingly, many of the strongly active compounds identified were natural products representing five diverse chemical classes (limonoids, curvularins, withanolides, celastraloids, and colletofragarones). All of these compounds share the same chemical motif, an α,β- unsaturated carbonyl functionality, with strong potential for thiol-reactivity. Despite the lack of a priori mechanistic requirements in our primary phenotypic screen, this motif was found to be necessary albeit not sufficient, for both heat-shock activation and inhibition of glioma tumor cell growth. Within the withanolide class, a promising therapeutic index for the compound withaferin A was demonstrated in vivo using a stringent orthotopic human glioma xenograft model in mice. Our findings reveal that diverse organisms elaborate structurally complex thiol-reactive metabolites that act on the stress responses of heterologous organisms including humans. From a chemical biology perspective, they define a robust approach for discovering candidate compounds that target the malignant phenotype by disrupting protein homeostasis.

AB - Unlike normal tissues, cancers experience profound alterations in protein homeostasis. Powerful innate adaptive mechanisms, especially the transcriptional response regulated by Heat Shock Factor 1 (HSF1), are activated in cancers to enable survival under these stressful conditions. Natural products that further tax these stress responses can overwhelm the ability to cope and could provide leads for the development of new, broadly effective anticancer drugs. To identify compounds that drive the HSF1-dependent stress response, we evaluated over 80,000 natural and synthetic compounds as well as partially purified natural product extracts using a reporter cell line optimized for high-throughput screening. Surprisingly, many of the strongly active compounds identified were natural products representing five diverse chemical classes (limonoids, curvularins, withanolides, celastraloids, and colletofragarones). All of these compounds share the same chemical motif, an α,β- unsaturated carbonyl functionality, with strong potential for thiol-reactivity. Despite the lack of a priori mechanistic requirements in our primary phenotypic screen, this motif was found to be necessary albeit not sufficient, for both heat-shock activation and inhibition of glioma tumor cell growth. Within the withanolide class, a promising therapeutic index for the compound withaferin A was demonstrated in vivo using a stringent orthotopic human glioma xenograft model in mice. Our findings reveal that diverse organisms elaborate structurally complex thiol-reactive metabolites that act on the stress responses of heterologous organisms including humans. From a chemical biology perspective, they define a robust approach for discovering candidate compounds that target the malignant phenotype by disrupting protein homeostasis.

UR - http://www.scopus.com/inward/record.url?scp=84863158295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863158295&partnerID=8YFLogxK

U2 - 10.1021/cb200353m

DO - 10.1021/cb200353m

M3 - Article

C2 - 22050377

AN - SCOPUS:84863158295

VL - 7

SP - 340

EP - 349

JO - ACS Chemical Biology

JF - ACS Chemical Biology

SN - 1554-8929

IS - 2

ER -